Global Proton Pump Inhibitors (PPIs) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Proton Pump Inhibitors (PPIs) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Proton-pump inhibitors (PPIs) are a group of medications whose main action is a pronounced and long-lasting reduction of stomach acid production.
Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.
PPIs are among the most widely sold medications in the world. The class of proton-pump inhibitor medications is on the World Health Organization's List of Essential Medicines.
Medically used proton pump inhibitorsOmeprazole, Lansoprazole, Dexlansoprazole, Esomeprazole, Pantoprazole, Rabeprazole.
Proton Pump Inhibitors (PPIs) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Proton Pump Inhibitors (PPIs) market is projected to reach US$ 15000 million in 2034, increasing from US$ 12190 million in 2022, with the CAGR of 2.9% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Global Proton Pump Inhibitors key players include AstraZeneca, Takeda, etc. Global top two manufacturers hold a share over 15%.
North America is the largest market, with a share about 30%, followed by Asia-Pacific, and Europe, having a share about 52 per୩
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Proton Pump Inhibitors (PPIs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AstraZeneca
Pfizer
Janssen
Eisai
Eli Lilly
Cadila Pharmaceuticals
Santarus
Wyeth
Changzhou Siyao Pharmaceuticals
Yangzhou Pharmaceutical
Segment by Type
Pantoprazole
Omeprazole
Lansoprazole
Esomeprazole
Rabeprazole
Others
Hospitals
Clinics
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Proton Pump Inhibitors (PPIs) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Proton Pump Inhibitors (PPIs), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Proton Pump Inhibitors (PPIs) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Proton Pump Inhibitors (PPIs) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Proton Pump Inhibitors (PPIs) introduction, etc. Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Proton Pump Inhibitors (PPIs) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.
PPIs are among the most widely sold medications in the world. The class of proton-pump inhibitor medications is on the World Health Organization's List of Essential Medicines.
Medically used proton pump inhibitorsOmeprazole, Lansoprazole, Dexlansoprazole, Esomeprazole, Pantoprazole, Rabeprazole.
Proton Pump Inhibitors (PPIs) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Proton Pump Inhibitors (PPIs) market is projected to reach US$ 15000 million in 2034, increasing from US$ 12190 million in 2022, with the CAGR of 2.9% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Global Proton Pump Inhibitors key players include AstraZeneca, Takeda, etc. Global top two manufacturers hold a share over 15%.
North America is the largest market, with a share about 30%, followed by Asia-Pacific, and Europe, having a share about 52 per୩
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Proton Pump Inhibitors (PPIs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AstraZeneca
Pfizer
Janssen
Eisai
Eli Lilly
Cadila Pharmaceuticals
Santarus
Wyeth
Changzhou Siyao Pharmaceuticals
Yangzhou Pharmaceutical
Segment by Type
Pantoprazole
Omeprazole
Lansoprazole
Esomeprazole
Rabeprazole
Others
Segment by Application
Hospitals
Clinics
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Proton Pump Inhibitors (PPIs) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Proton Pump Inhibitors (PPIs), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Proton Pump Inhibitors (PPIs) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Proton Pump Inhibitors (PPIs) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Proton Pump Inhibitors (PPIs) introduction, etc. Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Proton Pump Inhibitors (PPIs) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices